Your browser doesn't support javascript.
loading
Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED).
Tanaka, Atsushi; Okada, Yosuke; Torimoto, Keiichi; Kamei, Nozomu; Hirai, Hiroyuki; Kono, Teruyuki; Sugimoto, Kazuhiro; Teragawa, Hiroki; Taguchi, Isao; Maruhashi, Tatsuya; Sonoda, Satomi; Kurozumi, Akira; Inagaki, Saori; Oshita, Chikage; Hisauchi, Itaru; Takahashi, Kanae; Higashi, Yukihito; Shimabukuro, Michio; Node, Koichi.
Afiliación
  • Tanaka A; Department of Cardiovascular Medicine, Saga University, Saga, Japan. Electronic address: tanakaa2@cc.saga-u.ac.jp.
  • Okada Y; First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Torimoto K; First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Kamei N; Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomic Bomb Survivors Hospital, Hiroshima, Japan.
  • Hirai H; Department of Internal Medicine, Shirakawa Kosei General Hospital, Shirakawa, Japan.
  • Kono T; Department of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Sugimoto K; Diabetes Center, Ohta Nishinouchi Hospital, Koriyama, Japan.
  • Teragawa H; Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan.
  • Taguchi I; Department of Cardiology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
  • Maruhashi T; Department of Regenerative Medicine, Hiroshima University, Hiroshima, Japan.
  • Sonoda S; First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Kurozumi A; First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
  • Inagaki S; Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomic Bomb Survivors Hospital, Hiroshima, Japan.
  • Oshita C; Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan.
  • Hisauchi I; Department of Cardiology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
  • Takahashi K; Department of Biostatistics, Hyogo Medical University, Nishinomiya, Japan.
  • Higashi Y; Department of Regenerative Medicine, Hiroshima University, Hiroshima, Japan.
  • Shimabukuro M; Department of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Node K; Department of Cardiovascular Medicine, Saga University, Saga, Japan. Electronic address: node@cc.saga-u.ac.jp.
Diabetes Metab ; 49(4): 101447, 2023 07.
Article en En | MEDLINE | ID: mdl-37116858
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Diabetes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article Pais de publicación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Diabetes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article Pais de publicación: Francia